A detailed history of Hunter Associates Investment Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hunter Associates Investment Management LLC holds 8,821 shares of LLY stock, worth $6.62 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares
8,821
Previous 8,896 0.84%
Holding current value
$6.62 Million
Previous $8.05 Million 2.97%
% of portfolio
1.21%
Previous 1.35%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$772.14 - $960.02 $57,910 - $72,001
-75 Reduced 0.84%
8,821 $7.82 Million
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $819,103 - $1.03 Million
-1,130 Reduced 11.27%
8,896 $8.05 Million
Q4 2023

Jan 31, 2024

SELL
$525.19 - $619.13 $75,102 - $88,535
-143 Reduced 1.41%
10,026 $5.84 Million
Q3 2023

Nov 09, 2023

BUY
$434.7 - $599.3 $29,994 - $41,351
69 Added 0.68%
10,169 $5.46 Million
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $159,235 - $212,916
454 Added 4.71%
10,100 $4.74 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $48,232 - $56,200
150 Added 1.58%
9,646 $3.53 Million
Q3 2022

Nov 02, 2022

BUY
$296.48 - $337.87 $53,366 - $60,816
180 Added 1.93%
9,496 $3.07 Million
Q2 2022

Aug 10, 2022

SELL
$278.73 - $327.27 $2.54 Million - $2.98 Million
-9,112 Reduced 49.45%
9,316 $3.02 Million
Q4 2021

Jan 27, 2022

SELL
$224.85 - $279.04 $388,540 - $482,181
-1,728 Reduced 8.57%
18,428 $5.09 Million
Q2 2021

Aug 05, 2021

BUY
$180.55 - $233.54 $1.59 Million - $2.06 Million
8,833 Added 78.01%
20,156 $4.63 Million
Q1 2021

May 10, 2021

BUY
$164.32 - $212.72 $56,361 - $72,962
343 Added 3.12%
11,323 $2.12 Million
Q4 2020

Jan 29, 2021

SELL
$130.46 - $172.63 $143,506 - $189,893
-1,100 Reduced 9.11%
10,980 $1.85 Million
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $8,773 - $10,147
60 Added 0.5%
12,080 $1.79 Million
Q1 2020

May 11, 2020

BUY
$119.05 - $147.35 $833 - $1,031
7 Added 0.06%
12,020 $1.67 Million
Q4 2019

Feb 07, 2020

BUY
$106.92 - $132.43 $117,612 - $145,673
1,100 Added 10.08%
12,013 $1.58 Million
Q1 2019

May 10, 2019

SELL
$111.31 - $131.02 $11,131 - $13,102
-100 Reduced 0.91%
10,913 $1.42 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $8,163 - $9,636
110 Added 1.01%
11,013 $852,000
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $840,294 - $932,642
10,903
10,903 $933,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hunter Associates Investment Management LLC Portfolio

Follow Hunter Associates Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Associates Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Associates Investment Management LLC with notifications on news.